Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Lawrence Otto Klein Insider Profile

4 Followers

Lawrence Otto Klein, CEO, Director at Oruka Therapeutics, holds 923.13K shares in Oruka Therapeutics (Ticker: ORKA), holds 24.50K shares in Jasper Therapeutics (Ticker: JSPR), holds 26.80K shares in Crispr Therapeutics AG (Ticker: CRSP). Most recently, Lawrence Otto Klein Sold ― shares of Oruka Therapeutics on Sep 15, 2026 for an estimated value of $234.68K.

Lawrence Otto Klein's Trading History

ORKAOruka Therapeutics		Sep 15, 2026CEO, DirectorInformative Sell234.68K$89.42M
JSPRJasper Therapeutics		Oct 13, 2022DirectorUninformative Buy―$12.74K
CRSPCrispr Therapeutics AG		Mar 14, 2022CBO & COOUninformative Buy279.42K$1.38M
DYNDyne Therapeutics		Sep 23, 2020DirectorUninformative Buy―$179.00K
JBIOJade Biosciences		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Lawrence Otto Klein insider profile FAQ

What is the percentage of profitable transactions made by Lawrence Otto Klein?
The percentage of profitable transactions made by Lawrence Otto Klein is 0%.
What is the average return per transaction made by Lawrence Otto Klein?
The average return per transaction made by Lawrence Otto Klein is -60.00%.
What stocks does Lawrence Otto Klein hold?
Lawrence Otto Klein holds: ORKA, CRSP, JSPR, DYN, JBIO stocks.
What was Lawrence Otto Klein’s latest transaction?
Lawrence Otto Klein’s latest transaction was an Informative Sell of $234.68K.
What was Lawrence Otto Klein's most profitable transaction?
Lawrence Otto Klein’s most profitable transaction was an Informative Sell of ORKA stock on September 15, 2026. The return on the trade was -5.00%.
What is Lawrence Otto Klein's role in Oruka Therapeutics?
Lawrence Otto Klein's role in Oruka Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.